Perbak Capital Partners LLP Incyte Corp Transaction History
Perbak Capital Partners LLP
- $135 Billion
- Q1 2025
A detailed history of Perbak Capital Partners LLP transactions in Incyte Corp stock. As of the latest transaction made, Perbak Capital Partners LLP holds 3,339 shares of INCY stock, worth $214,530. This represents 0.15% of its overall portfolio holdings.
Number of Shares
3,339Holding current value
$214,530% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding INCY
# of Institutions
694Shares Held
194MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$1.98 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.37 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.28 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$955 Million0.55% of portfolio
-
State Street Corp Boston, MA10MShares$645 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $14.3B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...